Insider Selling: Bitwise MARA Option Income Strategy ETF (NYSEARCA:IMRA) Major Shareholder Sells $12,668,988.16 in Stock

Bitwise MARA Option Income Strategy ETF (NYSEARCA:IMRA) major shareholder Orbimed Advisors Llc sold 281,408 shares of the stock in a transaction on Monday, June 15th. The stock was sold at an average price of $45.02, for a total value of $12,668,988.16. Following the completion of the sale, the insider directly owned 245,728 shares in the company, valued at $11,062,674.56. This represents a 53.38% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Major shareholders that own more than 10% of a company’s stock are required to disclose their transactions with the SEC.

Bitwise MARA Option Income Strategy ETF Stock Performance

Shares of IMRA opened at $17.23 on Friday. Bitwise MARA Option Income Strategy ETF has a 1 year low of $11.99 and a 1 year high of $54.94. The company has a market cap of $3.27 million, a price-to-earnings ratio of 344.60 and a beta of 2.88. The firm has a fifty day moving average of $16.49 and a 200-day moving average of $15.83.

Bitwise MARA Option Income Strategy ETF Company Profile

IMARA Inc, a clinical-stage biopharmaceutical company, develops and commercializes therapeutics for patients with rare genetic disorders of hemoglobin. Its lead product candidate is IMR-687, an oral and once-a-day therapeutic that is in Phase 2b clinical trials for the treatment of sickle cell disease and ß-thalassemia. The company also develops IMR-261, an oral and clinical-ready activator of nuclear factor erythroid 2–related factor 2 for the treatment of hemoglobinopathies, iron disorders, and potentially other areas.